BioAdaptives, Inc. – OTC:BDPT
BioAdaptives stock price today
BioAdaptives stock price monthly change
BioAdaptives stock price quarterly change
BioAdaptives stock price yearly change
BioAdaptives key metrics
Market Cap | 128.39K |
Enterprise value | 430.59K |
P/E | -0.07 |
EV/Sales | 15.92 |
EV/EBITDA | -0.48 |
Price/Sales | 2.74 |
Price/Book | -0.05 |
PEG ratio | N/A |
EPS | N/A |
Revenue | 37.18K |
EBITDA | -241.15K |
Income | -731.98K |
Revenue Q/Q | 255.27% |
Revenue Y/Y | 147.57% |
Profit margin | -5499.38% |
Oper. margin | -2735.57% |
Gross margin | 41.52% |
EBIT margin | -2735.57% |
EBITDA margin | -648.55% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBioAdaptives stock price history
BioAdaptives stock forecast
BioAdaptives financial statements
| Jun 2023 | 2.33K | -143.91K | -6152.93% |
|---|---|---|---|
| Sep 2023 | 15.64K | -13.06K | -83.46% |
| Dec 2023 | 7.20K | -268.30K | -3725.89% |
| Mar 2024 | 11.99K | -306.70K | -2557.17% |
| Jun 2023 | 48273 | 1.72M | 3577.12% |
|---|---|---|---|
| Sep 2023 | 329302 | 1.47M | 447.96% |
| Dec 2023 | 103998 | 1.75M | 1683.33% |
| Mar 2024 | 58667 | 1.85M | 3164.56% |
| Jun 2023 | -56.86K | 0 | 91.04K |
|---|---|---|---|
| Sep 2023 | -56.14K | 0 | 168.1K |
| Dec 2023 | -91.29K | 32 | -108.03K |
| Mar 2024 | -41.18K | 0 | 0 |
BioAdaptives alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
BioAdaptives other data
| Period | Buy | Sel |
|---|---|---|
| Nov 2024 | 125000 | 0 |
| Insider | Compensation |
|---|---|
Mr. Robert W. Ellis (1942) Pres & Director | $20,000 |
Tuesday, 10 December 2024 | ||
| This Wide Moat ETF Could Be 2025 Star | etftrends.com | |
| BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health | globenewswire.com | |
Tuesday, 3 December 2024 | ||
| BioAdaptives, Inc.'s Board of Directors Approves a One-for-One Stock Dividend | globenewswire.com | |
Monday, 25 November 2024 | ||
| BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™ | globenewswire.com | |
Thursday, 21 November 2024 | ||
| BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace | globenewswire.com | |
Wednesday, 13 November 2024 | ||
| BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions | globenewswire.com | |
Tuesday, 29 October 2024 | ||
| BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split | globenewswire.com | |
Thursday, 30 May 2024 | ||
| BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors | globenewswire.com |
-
What's the price of BioAdaptives stock today?
One share of BioAdaptives stock can currently be purchased for approximately $0.02.
-
When is BioAdaptives's next earnings date?
Unfortunately, BioAdaptives's (BDPT) next earnings date is currently unknown.
-
Does BioAdaptives pay dividends?
No, BioAdaptives does not pay dividends.
-
How much money does BioAdaptives make?
BioAdaptives has a market capitalization of 128.39K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 66.31% to 28.57K US dollars.
-
What is BioAdaptives's stock symbol?
BioAdaptives, Inc. is traded on the OTC under the ticker symbol "BDPT".
-
What is BioAdaptives's primary industry?
Company operates in the Consumer Defensive sector and Packaged Foods industry.
-
How do i buy shares of BioAdaptives?
Shares of BioAdaptives can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BioAdaptives's key executives?
BioAdaptives's management team includes the following people:
- Mr. Robert W. Ellis Pres & Director(age: 83, pay: $20,000)
-
How many employees does BioAdaptives have?
As Jul 2024, BioAdaptives employs 3 workers.
-
When BioAdaptives went public?
BioAdaptives, Inc. is publicly traded company for more then 11 years since IPO on 9 Jul 2014.
-
What is BioAdaptives's official website?
The official website for BioAdaptives is shopbioadaptives.com.
-
Where are BioAdaptives's headquarters?
BioAdaptives is headquartered at 2620 Regatta Drive, Las Vegas, NV.
-
How can i contact BioAdaptives?
BioAdaptives's mailing address is 2620 Regatta Drive, Las Vegas, NV and company can be reached via phone at +7 026598829.
BioAdaptives company profile:
BioAdaptives, Inc.
shopbioadaptives.comOTC
3
Packaged Foods
Consumer Defensive
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Las Vegas, NV 89128
CIK: 0001575142
ISIN: US09072U1079
CUSIP: 09072U107
